期刊文献+

轻度认知障碍和阿尔茨海默病患者血白细胞介素-6水平变化 被引量:1

Changes of Serum IL-6 in Mild Cognitive Impairment and Alzheimer's Disease
暂未订购
导出
摘要 目的观察轻度认知障碍(MCI)和阿尔茨海默病(AD)患者血清白细胞介素-6(IL-6)水平变化。方法采用双抗体夹心酶联免疫吸附试验(ELISA)法检测AD 14例、MCI 14例和对照组11例的血清IL-6水平。结果 3组血清IL-6水平比较差异有统计学意义(P<0.05),MCI组和AD组血清IL-6水平均高于对照组(P<0.05),MCI组与AD组相比差异无统计学意义(P>0.05)。结论 MCI及AD均有炎症改变,提示炎症反应可能是AD发病机制中的一个重要环节,在AD进一步病理变化过程中可能起重要作用。 Objective To observe the diversity of serum IL-6 in patients with mild cognitive impairment(MCI)and Alzheimer's disease(AD).Methods The IL-6 content in serum of AD(n=14)、MCI(n=14)and controls(n=11)were detected by double-antibody sandwich method of enzyme linked immunosorbent assay(ELISA).Results The difference of serum IL-6 among three groups was significant(P〈0.05).the serum IL-6 in MCI group and AD group were significant higher than that of the controls(P〈0.05).No significant difference between was found between MCI group and AD group(P〉0.05).Conclusion There is inflammation change in both MCI and AD patients,suggesting inflammatory reaction is a possible key component element of the pathological mechanism of AD,and possibly make important effect on further pathological development of AD.
出处 《广西医学》 CAS 2010年第12期1469-1471,共3页 Guangxi Medical Journal
基金 广西科学基金(桂科自0728133) 广西医药卫生科学研究基金(桂卫科Z2006045)
关键词 阿尔茨海默病 认知障碍 白细胞介素-6 Alzheimer's disease Cognitive impairment Interleukin-6
  • 相关文献

参考文献11

  • 1Sramek JJ,Veroff AE,Cutler NR.Mild cognitive impairment:emerging therapeutics[J].Ann Pharmacother,2000,34(10):1 179-1 188.
  • 2吴传深,周东丰,管振全.血浆IL-6水平与阿尔茨海默病[J].中国神经免疫学和神经病学杂志,2003,10(2):87-89. 被引量:8
  • 3Petersen RC,Smith GE,Waring SC,et al.Mild cognitive impairment:clinical characterization and outcome[J].Arch Neurol,1999,56(3):303-308.
  • 4McGeer EG,Mc Geer PL.The importance of inflammatory mechanisms in Alzheimer's disease[J].Exp Gerontol,1998,33(5):371-378.
  • 5Schubert P,Morino T,Miyazaki H,et al.Cascading glia reactions:a common pathomechanism and its differentiated control by cyclic nucleotide signaling[J].Ann N Y Acad Sci,2000,903(1):24-33.
  • 6曹姣妃,刘宁,梁德胜,裴世澄.急性脑血管病患者血清hs-CRP,TNF-α和IL-6的动态变化及临床意义[J].第四军医大学学报,2004,25(2):173-175. 被引量:44
  • 7Rachon D,Mysliwska J,Suchecka-rachon K,et al.Serum interleukin-6 levels and bone mineral density at the femoral neck in post-menopausal women with Type 1 diabetes[J].Diabet Med,2003,20(6):475-480.
  • 8Loddick SA,Tumbull AV,Rothwell NJ.Cerebral Interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat[J].Cereb Blood Flow Metab,1998,18(2):176-179.
  • 9Campbell IL.Transgenic mice and cytokine actions in the brain:bridging the gap between structural and functional neuropathology[J].Brain Res Brain Res Rev,1998,26(2-3):327-336.
  • 10Czlonkowska A,Kurkowska-jastrzebska I.The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes[J].Neurol Neurochir Pol,2002,36(1):15-23.

二级参考文献13

  • 1杨金升.肿瘤坏死因子在脑卒中时的表达及作用[J].国外医学(脑血管疾病分册),1996,4(2):77-80. 被引量:71
  • 2刘立.局灶性脑缺血早期过程中的炎症及其损伤作用[J].国外医学(脑血管疾病分册),1996,4(1):3-5. 被引量:41
  • 3[1]Strauss S,Bauer J,Ganter U,et al. Detction of interleukin-6 and alpha-2 macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients[J]. Lab Invest, 1992,66(2):223-230.
  • 4[2]Huell M,Strauss S,Volk B,et al. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients[J]. Acta Neuropathol(berl), 1995,89(6):544-551.
  • 5[3]Bonaccorso S,Lin A,Song C,et al. Seroto-nine-immune interactions in elderly volunteers and in patients with Alzheimer's disease DAT: lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT[J]. Aging (Milano), 1998,10: 316-323.
  • 6[4]Angelis P,Scharf S,Mander A,et al. Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease[J]. Neurosci Lett, 1998,244(2):106-108.
  • 7[5]Alvarez XA,Franco A,Fernandez-Novoa F,et al. Blood levels of histamine, IL-1 beta and TNF-alpha in patients with mild to moderate Alzheimer's disease[J]. Mol Chem Neuropathol, 1996,29:237-252.
  • 8[6]McGeer PL,Schulzer M,McGeer EG.Arthritis and anti-in-flammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies[J]. Neurology, 1996,47:425-432.
  • 9[7]Mrak RE,Sheng JG,Griffin ST.Glial cytokines in Alzheimer's disease: review and pathogenetic implications[J]. Hum Pathol, 1995,26:816-823.
  • 10[8]Hampel H,Schoen D,Schwarz MJ,et al. Interleukin-6 is not altered in cerebrospinalfluid of first-degree relatives and patients with Alzheimer's disease[J]. Neurosci Lett, 1997,228:143-146.

共引文献50

同被引文献14

  • 1Ringman JM, Medina LD, Rodriguez - Agudelo Y, et al. Current concepts of mild Cognitive imparment and their applicability to per- sons at risk for familial Alzheimer's disease [ J ]. Curr Alzheimer Res,2009,6(4) :341 - 346.
  • 2Konstadina G, Jan S, Matthew H, et al. Cognitive impairment and 7 -year mortality in dialysis patients[ J]. Am J kidney Dis,2010, 56(4) : 693 -703.
  • 3Rogers J, Mastroeni , Leonard B, et al. Neuroinflamonation in Alzheimer' s disease and parkinson' s disease. Are microglia Pathogenic in either disorder[ J] ? Int Rev neurobiol, 2007, 82 ( 1 ) :235 - 246.
  • 4Marioni RE, Strachan Mw, Reynolds RM, et al. Association be- tween raised inflammatory markers and cognitive decline in elder people with type 2 diabetes : the Edinburgh Type 2 Diabetes study [ J]. Diabetes, 2010, 59:710 - 713.
  • 5Murray AM. Cognitive imparment in the aging dialysis and chronic kidney disease population : an occult burden[ J]. A Dv chronic kid- ney Dis,2008,15(2) :123 -132.
  • 6Jung S, Lee. YK, Choi SR, et al. relationship between Cognitive im- parment and depression D in Dialysis Patients[ J]. Yonsei Med J, 2013,54(6) :1447 - 1453.
  • 7Razani J, Wong JT, Dafaeeboini N, et al. Predicting everyday func- tional abilities of dementia patient with the Mini - mental state ex- amination [ J ]. Geriatric Psychiatry Neurol,2009,22 ( 1 ) :62 - 70.
  • 8Papaliag Ras V, kimiskidis V, Tsolaki M, et al. Usefulness of e- vent - related potentials in the assessment of mild cognitive impair- ment [ J]. BMC Nenrosci ,2008,5 ( 1 ) : 107 - 108.
  • 9Kalirao P, Pederson S, Foley RN, et al, Congnitive impairment in peritoneal dialysis patients [ J ]. Am J Kidney Dis, 2011,57 ( 4 ) : 612 -620.
  • 10Flinch CE, Morgan TE. Systemic inflammation, infection ApoE. AIeles, and Alzheimer' s disease; a position paper[J] Curr AlzheimerRes, 2007,4 (2) : 185 - 189.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部